Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2011-05-19

Clinical Trial Update: Evaluation of Combined Action Between Natrecor and Furosemide on Kidney and Neurohormone Responses in Chronic Heart Failure: A Phase-IV study704.351 / DSS [Phase 4]

View source ↗

Summary

A Phase 4 study evaluating the combined action of natrecor (nesiritide) and furosemide on kidney and neurohormonal responses in chronic heart failure; the trial…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • FUROSEMIDE (Furosemide)
  • Natrecor (nesiritide)

Snippet

Sponsor: Scios, Inc. | Conditions: Congestive Heart Failure, Chronic Heart Failure | Phase 4 | Status: COMPLETED